ReviewCrop health2024
CRISPR/Cas-mediated germplasm improvement and new strategies for crop protection.
Review in Crop health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Harnessing CRISPR-Cas technology for insect pest control: current advances and future perspectives.Molecular biology reports · 2026Review
- Engineering Plant-Associated Microorganisms for Bioremediation and Sustainable Agriculture.Microorganisms · 2026Review
- Article
- Simultaneous knockout of multipleaBIOTECH · 2025Article
- Bacterial vector-borne plant diseases: global issues caused by three-way interactions.Crop health · 2025Review
- Wheat resistance to Fusarium head blight and breeding strategies.Crop health · 2025Review
- CRISPR/Cas-Mediated Genome Engineering in Plants: Application and Prospectives.Plants (Basel, Switzerland) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Global agriculture and food security are encountering unprecedented challenges from both the ever-growing population and rapidly changing climate conditions. CRISPR/Cas-mediated genome editing technology has revolutionized plant functional genetic research and precision crop breeding with robustness, high target specificity and programmability. Furthermore, numerous emerging biotechnologies based on the CRISPR/Cas platform provide the opportunity to create new crop germplasms with durable resistance against disease or insect pests, herbicide tolerance, and other stress-tolerant improvements, reshaping crop protection to increase agricultural resilience and sustainability. In this review, we briefly describe the CRISPR/Cas toolbox, including base editing, prime editing, compact genome manipulation, transcriptional regulation and epigenetic editing, and then overview the most important applications of CRISPR/Cas-mediated crop genetic improvement, highlighting crop protection-based stress resistance engineering. In addition, we enumerate global regulations on genome-edited crops. Finally, we discuss some bottlenecks facing this cutting-edge technology and infinite possibilities for the future.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.